"Allergic rhinitis and its impact on asthma (ARIA)" has been the most preferred reference for national guidelines.The ARIA 2010 revision is the first evidence-based clinical guideline in the field of allergies,which has great influence in the world.The ARIA 2016 revision continues the basic framework of the 2010 revision,which focuses on six controversial clinical issues in the treatment of allergic rhinitis.It aimed to provide clear informationand systematic treatment for patients,clinicians and health policy makers.The interpretation of the ARIA 2016 revision will help domestic otolaryngologist,respiratory doctors,and allergy practitioners understand the latest guidelines for AR drug treatment in the world.